Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells
Journal of Gastroenterology and Hepatology · 2025
DOI: 10.1111/jgh.16802 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2025. Verfasst von Xixi Zeng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Hepatic Stellate Cells, Cell Proliferation, Liver Cirrhosis, TRPC6 Cation Channel. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background and Aim Hepatic fibrosis is a common outcome of chronic liver injury and can eventually lead to cirrhosis, which is a major public health concern. Hepatic stellate cells (HSCs) are the major producers of extracellular matrix (ECM) and regulate the synthesis and decomposition of ECM, but the specific mechanism of them remains unclear. Transient receptor potential channel 6 (TRPC6), a non‐selective cation channel, plays an important role in organic fibrosis. However, the role of TRPC6 in liver fibrosis is rarely studied.
Methods
Here, we investigated the function of TRPC6 in the activation of the human hepatic stellate cell line LX‐2 in vitro and bile duct ligation (BDL)‐induced hepatic fibrosis in vivo by western blot, Ca 2+ imaging, and immunohistochemistry.
Results
We first found that TRPC6 was upregulated in fibrotic liver tissues and TRPC6 knockout inhibited BDL‐induced hepatic fibrosis. Transforming growth factor‐β1 (TGF‐β1) treatment increased TRPC6 expression and thapsigargin (Tg)‐mediated SOCE in LX‐2 cells, which was decreased by the TRPC6 specific inhibitor SAR7334. Blockage of TRPC6 by SAR7334 or TRPC6‐shRNA transfection attenuated TGF‐β1‐induced LX‐2 cell activation and proliferation via the PI3K/AKT/p70S6K signaling pathway.
Conclusions
These observations suggested that TRPC6 contribute to LX‐2 cell activation and hepatic fibrosis, and downregulation of TRPC6 may become a therapeutic strategy for the treatment of hepatic fibrosis in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Renmin Hospital of Wuhan University, Wuhan, China.
- Department of Anatomy, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
- Department of Pain, Union Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Xixi Zeng
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zeng, X., Liao, Y., & Cheng, W. (2025). Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16802
Vancouver
Zeng X, Liao Y, Cheng W. Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells. Journal of Gastroenterology and Hepatology. 2025. doi:10.1111/jgh.16802
BibTeX
@article{Zeng2025,
author = {Zeng, Xixi and Liao, Yanhong and Cheng, Weiyi},
title = {Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells},
journal = {Journal of Gastroenterology and Hepatology},
year = {2025},
doi = {10.1111/jgh.16802}
}
EUVIMED